Ms Anuradha Acharya, CEO of the Hyderabad-based life science R&D enabling company, said, "Ocimum completed the acquisition of this division recently and we are happy to continue the superior technology offered by these chips. We also plan to retain most of MWG's GD (genomic diagnosis) business customers and offer newer products and services."
While these operations will continue in Germany, Ocimum said it planned to start wet lab services in India soon.
